Company Focuses on Finding Coronavirus Antibodies in Push for New Therapeutics

Beyond Testing: The Importance of Antibodies in Tackling Covid-19

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Engineering During a Pandemic

The Race to Find a Covid-19 Drug in the Blood of Survivors

Timeline Shows 3 Paths to COVID-19 Treatment and Prevention

How the Coronavirus Validated Berkeley Lights’ Technology and Its Supply Chain

GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours

2019 Top 10 Innovations

Ginkgo Bioworks Taps Cell-Engineering Startup to Advance Services

Screening Living Cells at High Speed

Achieving Unique Synergies in Antibody Expression

Indistinguishable from Magic? Meet Berkeley Lights

The Engineering of Living Organisms Could Soon Start Changing Everything

The 2019 World’s Most Innovative Companies

Catalent Invests $200M in Fast-Growing Biologics Manufacturing Business

New Technology Speeds Discovery of Novel, Rare Therapeutic Antibodies

New Berkeley Lights Workflow Speeds Up Drug Discovery